Duration of protective effect from inhaled ipratropium bromide on methacholine airway hyperresponsiveness

Trial Profile

Duration of protective effect from inhaled ipratropium bromide on methacholine airway hyperresponsiveness

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 May 2009

At a glance

  • Drugs Ipratropium bromide (Primary)
  • Indications Asthma
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 01 May 2009 Results reported in Annals of Allergy, Asthma and Immunology.
    • 20 Jul 2008 Actual patient number (12) added as reported by ClinicalTrials.gov.
    • 20 Jul 2008 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top